On October 29, beijing balance medical technology co., ltd. (688198.SH) announced that in the first three quarters of 2024, it achieved total operating income of 0.292 billion yuan, a year-on-year increase of 13.57%; net income attributable to shareholders of the parent company decreased by 16.56% to 58.6934 million yuan; and the basic earnings per share was 0.43 yuan.
佰仁医疗(688198.SH)：前三季度净利润5869.34万元，同比下降16.56%
beijing balance medical technology co., ltd. (688198.SH): The net income in the first three quarters was 58.6934 million yuan, a year-on-year decrease of 16.56%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated